Patent · US Active

Carbamate/urea derivatives

US9624192B2 · kind B2 · utility

9Cited by

3References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Yves Auberson · Allschwil, CH
Mark G. Bock · Hatfield, US
Dario Braga · Bologna, IT
Marco Curzi · Bologna, IT
Stephanie Kay Dodd · Ayer, US
Stefano Luca Giaffreda · Bologna, IT
Haiyang Jiang · Shanghai, CN
Piotr H. Karpinski · Lincoln Park, US
Thomas J. Troxler · Wahlen, CH
Tie-Lin Wang · Shanghai, CN
Xiaoyang Wang · Shanghai, CN
Xuechun Zhang · Hangzhou City, CN

Key dates

Filing date	Feb 22, 2016
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Feb 22, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compound of the formula Ior a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.